Morteza Karimipoor

1.4k total citations
101 papers, 1.1k citations indexed

About

Morteza Karimipoor is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Morteza Karimipoor has authored 101 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 26 papers in Hematology and 23 papers in Genetics. Recurrent topics in Morteza Karimipoor's work include Hemoglobinopathies and Related Disorders (20 papers), MicroRNA in disease regulation (13 papers) and Iron Metabolism and Disorders (12 papers). Morteza Karimipoor is often cited by papers focused on Hemoglobinopathies and Related Disorders (20 papers), MicroRNA in disease regulation (13 papers) and Iron Metabolism and Disorders (12 papers). Morteza Karimipoor collaborates with scholars based in Iran, United States and France. Morteza Karimipoor's co-authors include Sirous Zeinali, Reza Mahdian, Kayhan Azadmanesh, Masoud Soleimani, Ehsan Arefian, Samira Mohammadi‐Yeganeh, Mahdi Paryan, Sirous Zeinali, Elham Tafsiri and Ladan Teimoori‐Toolabi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Morteza Karimipoor

91 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morteza Karimipoor Iran 17 727 304 198 172 166 101 1.1k
Ignacio García‐Tuñón Spain 22 788 1.1× 224 0.7× 92 0.5× 220 1.3× 68 0.4× 45 1.5k
Liubin Yang United States 13 917 1.3× 273 0.9× 163 0.8× 118 0.7× 513 3.1× 24 1.4k
Enrico Cappelli Italy 19 1.2k 1.7× 333 1.1× 126 0.6× 155 0.9× 234 1.4× 69 1.6k
Simeon Santourlidis Germany 24 1.0k 1.4× 310 1.0× 69 0.3× 82 0.5× 104 0.6× 53 1.7k
H. Elizabeth Broome United States 12 516 0.7× 110 0.4× 80 0.4× 92 0.5× 121 0.7× 29 1.1k
Oliver M. Dovey United Kingdom 12 962 1.3× 88 0.3× 93 0.5× 118 0.7× 133 0.8× 17 1.1k
Keiichi I. Nakayama Japan 14 745 1.0× 145 0.5× 104 0.5× 91 0.5× 237 1.4× 22 1.2k
Kirsten Canté-Barrett Netherlands 17 529 0.7× 92 0.3× 46 0.2× 86 0.5× 240 1.4× 33 1.1k
Madeleine Carreau Canada 18 1.6k 2.2× 487 1.6× 48 0.2× 273 1.6× 219 1.3× 44 1.9k

Countries citing papers authored by Morteza Karimipoor

Since Specialization
Citations

This map shows the geographic impact of Morteza Karimipoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morteza Karimipoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morteza Karimipoor more than expected).

Fields of papers citing papers by Morteza Karimipoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morteza Karimipoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morteza Karimipoor. The network helps show where Morteza Karimipoor may publish in the future.

Co-authorship network of co-authors of Morteza Karimipoor

This figure shows the co-authorship network connecting the top 25 collaborators of Morteza Karimipoor. A scholar is included among the top collaborators of Morteza Karimipoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morteza Karimipoor. Morteza Karimipoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noormohammadi, Zahra, et al.. (2025). Cabergoline’s Promise in Endometriosis: Restoring Molecular Balance to Improve Reproductive Potential. Gynecologic and Obstetric Investigation. 91(1). 10–25. 1 indexed citations
2.
Shamaei, Masoud, et al.. (2024). Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues. PubMed. 28(1). 53–58. 3 indexed citations
3.
Karimipoor, Morteza, et al.. (2024). Mutations in COL6A Gene Family Responsible for Muscular Dystrophies in Three Unrelated Families. PubMed. 28(5). 297–304.
4.
Meskini, Maryam, Amir Amanzadeh, Morteza Karimipoor, et al.. (2024). Epigenetic modulation of cytokine expression in Mycobacterium tuberculosis-infected monocyte derived-dendritic cells: Implications for tuberculosis diagnosis. Cytokine. 181. 156693–156693. 5 indexed citations
5.
Meskini, Maryam, Amir Amanzadeh, Fahimeh Salehi, et al.. (2024). A protocol to isolate and characterize pure monocytes and generate monocyte-derived dendritic cells through FBS-Coated flasks. Scientific Reports. 14(1). 23956–23956.
6.
7.
Khosravi, Mohammad, et al.. (2023). CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications. PubMed Central. 27(5). 219–246. 11 indexed citations
8.
Amiri, Fahimeh Bagheri, et al.. (2023). Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions. Hemoglobin. 47(4). 163–166. 1 indexed citations
9.
Khosravi, Mohammad, et al.. (2022). Lentiviral vector containing beta-globin gene for beta thalassemia gene therapy. Gene Reports. 27. 101615–101615. 3 indexed citations
10.
Tarashi, Samira, Morteza Karimipoor, Seyed Davar Siadat, & Andrea Fuso. (2021). Epigenetic Modifications in host–Bacterial Dialogues: More than Meets the Eye. Epigenomics. 14(1). 5–9.
11.
Ehsani, Parastoo, et al.. (2019). A preliminary data of a prospective study on Iranian patients with osteogenesis imperfecta. Bone Abstracts. 1 indexed citations
12.
Khosravi, Mohammad, Jean‐Paul Concordet, Johannes vom Berg, et al.. (2019). Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. European Journal of Pharmacology. 854. 398–405. 59 indexed citations
13.
Karimipoor, Morteza, et al.. (2017). The Evaluation of miR-21 Level in Lung Tissue and Plasma of Nsclc Patients. SHILAP Revista de lepidopterología. 9(4). 13–21. 1 indexed citations
14.
Kokabee, Leila, Xianhui Wang, Christopher J. Sevinsky, et al.. (2015). Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer. Cancer Biology & Therapy. 16(11). 1604–1615. 34 indexed citations
15.
Karimipoor, Morteza, et al.. (2013). FREQUENCY OF ALPHA THALASSEMIA CARRIERS DETECTED IN TEHRAN PREMARRIAGE SCREENING USING MOLECULAR TECHNIQUES. Scientific Journal of Iran Blood Transfus Organ. 9(437). 414–421. 1 indexed citations
16.
Kokabee, Leila, et al.. (2013). Analysis of Intron 1 Inversion at F8 Gene in Severe Hemophilia A Patients by Inverse Shifting-PCR Referred from Isfahan Seyedolshohada Hospital. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Karimipoor, Morteza, et al.. (2011). ANALYSIS OF β GLOBIN GENE MUTATIONS AND G γ XMNI POLYMORPHISM IN THALASSEMIA INTERMEDIA PATIENTS REFERRED TO ALI-ASGHAR HOSPITAL, TEHRAN. Scientific Journal of Iran Blood Transfus Organ. 8(130). 20–31. 2 indexed citations
18.
Hamid, Mohammad, et al.. (2011). RELATIONSHIP BETWEEN DNA POLYMORPHISMS AT THE BCL11A AND HBS1L-MYB LOCI IN β- THALASSEMIA PATIENTS WITH INCREASED FETAL HEMOGLOBIN LEVELS. Scientific Journal of Iran Blood Transfus Organ. 8(332). 149–157. 2 indexed citations
19.
Sayyah, Mohammad, et al.. (2010). Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients.. PubMed. 14(3). 89–96. 25 indexed citations
20.
Mahdian, Reza, et al.. (2009). Validation and comparison of two quantitative real-time PCR assays for direct detection of DMD/BMD carriers. Clinical Biochemistry. 42(12). 1291–1299. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio García‐Tuñón Breakdown of academic impact, for papers by Liubin Yang Breakdown of academic impact, for papers by Enrico Cappelli Breakdown of academic impact, for papers by Simeon Santourlidis Breakdown of academic impact, for papers by H. Elizabeth Broome Breakdown of academic impact, for papers by Oliver M. Dovey Breakdown of academic impact, for papers by Keiichi I. Nakayama Breakdown of academic impact, for papers by Kirsten Canté-Barrett Breakdown of academic impact, for papers by Madeleine Carreau
Rankless by CCL
2026